Search Results - "Isabel Martín-Herranz"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis by Elberdín, Laida, Fernández-Torres, Rosa M, Mateos, María, Outeda, María, Blanco, Eva, Gómez-Besteiro, María I, Martín-Herranz, Isabel, Fonseca, Eduardo

    Published in Frontiers in medicine (08-12-2022)
    “…There is growing evidence that therapeutic drug monitoring of biologic therapy is beneficial in psoriatic patients. With respect to ustekinumab, the available…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Analysing Early Diagnosis Strategies for HIV Infection: A Retrospective Study of Missed Diagnostic Opportunities by Giménez-Arufe, Víctor, Rotea-Salvo, Sandra, Martínez-Pradeda, Alejandro, Mena-de-Cea, Álvaro, Margusino-Framiñán, Luis, Suanzes-Hernández, Jorge, Martín Herranz, María Isabel, Cid-Silva, Purificación

    Published in Healthcare (Basel) (01-01-2024)
    “…Early diagnosis of a Human Immunodeficiency Virus (HIV)-infected person represents a cornerstone of HIV prevention, treatment, and care. Numerous publications…”
    Get full text
    Journal Article
  9. 9

    Neurotoxicity associated with acyclovir and valacyclovir: A systematic review of cases by Brandariz‐Nuñez, David, Correas‐Sanahuja, Marcelo, Maya‐Gallego, Sara, Martín Herranz, Isabel

    “…What is known and objective Acyclovir and valacyclovir are commonly used antivirals with good general tolerance. Despite their good safety profile, they can…”
    Get full text
    Journal Article
  10. 10

    Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors by Cid-Silva, Purificación, Margusino-Framiñán, Luis, Balboa-Barreiro, Vanesa, Martín-Herranz, Isabel, Castro-Iglesias, Ángeles, Pernas-Souto, Berta, Llibre, Josep M, Poveda, Eva

    Published in AIDS (London) (02-01-2018)
    “…HIV-1 subtype B (54.4%) and subtype F (27.2%) are the most prevalent variants in patients who started antiretroviral therapy including an integrase inhibitor…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Management of Everolimus and Voriconazole Interaction in Lung Transplant Patients by Outeda Macías, María, Salvador Garrido, Pilar, Elberdín Pazos, Laida, Martín Herranz, María Isabel

    Published in Therapeutic drug monitoring (01-06-2016)
    “…To analyze the impact of voriconazole administration on everolimus dose, trough concentrations and concentration/dose (C0/D) ratio in order to determine the…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    [Translated article] Hospital pharmacy towards 2030 by Fernández de Gamarra-Martínez, Edurne, Tortajada-Goitia, Begoña, Corte-García, Juan José, Martín-Herranz, Isabel, García-Gil, Mario, Sáez de la Fuente, Javier, Nicolás-Picó, Jordi

    Published in Farmacia hospitalaria (01-07-2024)
    “…Hospital Pharmacy is today a profession marked by therapeutic advances, with a proactive attitude, focussed on people and their health. The evolution of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting by García-Queiruga, M, Feal Cortizas, B, Lamelo Alfonsín, F, Pertega Diaz, S, Martín-Herranz, I

    Published in Revista española de quimioterapia (01-06-2021)
    “…To describe the avoided costs and to analyze the effectiveness of intravenous antibiotic treatment in continuous perfusion in patients at Hospital at Home…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Lipid profile changes associated with antiretroviral therapies in a real-world cohort by Rotea-Salvo, Sandra, Giménez-Arufe, Víctor, Martínez-Pradeda, Alejandro, Fernández-Oliveira, Carla, Mena-de-Cea, Álvaro, Margusino-Framiñán, Luis, Martín-Herranz, Isabel, Cid-Silva, Purificación

    Published in Farmacia hospitalaria (01-09-2023)
    “…To compare lipid profile changes and cardiovascular events among HIV naïve and experienced patients from a real-world cohort treated with…”
    Get full text
    Journal Article